Marijuana and the Cannabinoids

Human Cannabinoid Pharmacokinetics 231
49. Widman, M., Nordqvist, M., Dollery, C. T., and Briant, R. H. (1975) Metabolism of
delta-1-tetrahydrocannabinol by the isolated perfused dog lung. Comparison with in vitro
liver metabolism. J. Pharm. Pharmacol. 27, 842–848.
50. Harvey, D. J. and Paton, W. D. M. (1984) Metabolism of the cannabinoids. Rev. Biochem.
Toxicol. 6, 221–264.
51. Mechoulam, R., BenZvi, Z., Agurell, S., et al. (1973) Delta-6 tetrahydrocannabinol-7-oic
acid, a urinary delta-6-THC metabolite: isolation and synthesis. Experientia 29, 1193–1195.
52. Sporkert, F., Pragst, F., Ploner, C. J., Tschirch, A., and Stadelmann, A. M. (2001) Pharmacokinetic
investigations and delta-9-tetrahydrocannabinol and its metabolites after
single administration of 10 mg Marinol in attendance of a psychiatric study. The Annual
Meeting of The International Association of Forensic Toxicologists, Prague, Czech Republic,
Abstract P62.
53. Halldin, M. M., Widman, M., Bahr, C. V., Lindgren, J. E., and Martin, B. R. (1982)
Identification of in vitro metabolites of delta1-tetrahydrocannabinol formed by human
livers. Drug Metab. Dispos. 10, 297–301.
54. Garrett, E. R. and Hunt, C. A. (1977) Pharmacokinetics of delta-9-tetrahydrocannabinol
in dogs. J. Pharm. Sci. 66, 395–407.
55. Williams, P. L. and Moffat, A. C. (1980) Identification in human urine of delta-9-tetrahydrocannabinol-11-oic
glucuronide: a tetrahydrocannabinol metabolite. J. Pharm.
Pharmacol. 32, 445–448.
56. Huestis, M. A., Mitchell, J. M., and Cone, E. J. (1996) Urinary excretion profiles of 11-
nor-9-carboxy-∆ 9 -tetrahydrocannabinol in humans after single smoked doses of marijuana.
J. Anal. Toxicol. 20, 441–452.
57. Huestis, M. A. and Cone, E. J. (1998) Urinary excretion half-life of 11-nor-9-carboxydelta-9-tetrahydrocannabinol
in humans. Ther. Drug Monit. 20, 570–576.
58. Johansson, E. and Halldin, M. M. (1989) Urinary excretion half-life of delta1-tetrahydrocannabinol-7-oic
acid in heavy marijuana users after smoking. J. Anal. Toxicol. 13, 218–
223.
59. Cone, E. J., Johnson, R. E., Paul, B. D., Mell, L. D., and Mitchell, J. (1988) Marijuanalaced
brownies: Behavioral effects, physiologic effects, and urinalysis in humans following
ingestion. J. Anal. Toxicol. 12, 169–175.
60. Gustafson, R. A., Levine, B., Stout, P. R., et al. (2003) Urinary cannabinoid detection
times after controlled oral administration of delta-9-tetrahydrocannabinol to humans.
Clin. Chem. 49, 1114–1124.
61. Kemp, P. M., Abukhalaf, I. K., Manno, J. E., et al. (1995) Cannabinoids in humans. II.
The influence of three methods of hydrolysis on the concentration of THC and two metabolites
in urine. J. Anal. Toxicol. 19, 292–298.
62. Mason, A. P. and McBay, A. J. (1985) Cannabis: pharmacology and interpretation of
effects. J. Forensic Sci. 30, 615–631.
63. Moskowitz, H. (1985) Marijuana and driving. Accid. Anal. Prev. 17, 323–345.
64. Kurzthaler, I., Hummer, M., Miller, C., et al. (1999) Effect of cannabis use on cognitive
functions and driving ability. J. Clin. Psychiatry 60, 395–399.
65. Ramaekers, J. G., Berghaus, G., van Laar, M., and Drummer, O. H. (2004) Dose related
risk of motor vehicle crashes after cannabis use. Drug Alcohol Depend. 73, 109–119.
66. O’Kane, C. J., Tutt, D. C., and Bauer, L. A. (2002) Cannabis and driving: a new perspective.
Emerg. Med. 14, 296–303.
67. Lukas, S. E. and Orozco, S. (2001) Ethanol increases plasma delta-9-tetrahydrocannabinol
(THC) levels and subjective effects after marihuana smoking in human volunteers.
Drug Alcohol Depend. 64, 143–149.
68. Ramaekers, J. G., Robbe, H. W., and O’Hanlon, J. F. (2000) Marijuana, alcohol and
actual driving performance. Hum. Psychopharmacol. 15, 551–558.